EquityFlowCompanies › MultivisionDx

MultivisionDx

Healthtech · Helsinki, FI

Piattaforma AI di biologia spaziale che crea 'impronte digitali' del tumore per predire la risposta alle terapie.

Funding history

DateRoundAmount
Dec 2025Pre Seed
Helsinki-based MultivisionDx, a University of Helsinki spinout, raised a 1 million euro pre-seed led by Antler for AI-based precision cancer diagnostics.
$1.2M

Investors

AntlerHelsinki University FundsKaikarhenni Oy

Similar companies in Healthtech

Explore funding flow on EquityFlow →